Clinical trial
Can Venous Lactate Predict the Progression to Overt Septic Shock and Mortality in Non-elderly Sepsis Patients Without Hemodynamic Shock in Emergency Department?
NCT01947127 is registered in ClinicalTrials.gov with Chulalongkorn University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Can Venous Lactate Predict the Progression to Overt Septic Shock and Mortality in Non-elderly Sepsis Patients Without Hemodynamic Shock in Emergency Department?
- Lead sponsor
- Chulalongkorn University
- Phase
- Observational
- Overall status
- Completed
- Start date
- March 31, 2013
- Completion date
- January 31, 2015
- Enrollment
- 458 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
disease progression, fatal outcome, sepsis, septic shock